Table 2.
Reported Affinities of Inhibin and Activin Isoforms for Activin Receptors and Betaglycan
Receptor | Competing Ligands |
Refs. | |||
---|---|---|---|---|---|
Activin A | Activin B | Inhibin A | Inhibin B | ||
ActRII Ki (HEK293 cells) | 6.3 nm | 217 | |||
ActRII Kd - displacing I125 activin A or B | 49.3 ± 25 pm | 3240 ± 224 pm | 151 | ||
ActRII ED50 - displacing I125 activin A | 0.73 ± 0.09 ng | 3.26 ± 1.29 ng | 15.8 ± 0.39 ng | 23.7 ± 2.59 ng | 151 |
ActRII ED50 - displacing I125 activin B | 0.50 ± 0.25 ng | 3.75 ± 1.02 ng | 19.3 ± 6.02 ng | 12.9 ± 2.62 ng | 151 |
ActRIIB-ECD Kd - BIAcore chip analysis | 0.24 nm | 13.1 nm | 131 | ||
ActRIIB-ECD (single) Kd -BIAcore chip analysis | 6.9 nm | 3.7 nm | 131 | ||
ActRIIB2 (IC50) - displacing I125 inhibin A | 2.2 nm | 75.5 nm | 20.7 nm | 218 | |
ActRIIB2 (IC50) - displacing I125 inhibin B | 5.9 nm | 4.5 nm | 218 | ||
BG Ki (HEK293 cells) | 0.6 nm | 217 | |||
BG (IC50) - displacing I125 inhibin B | 329 pm | 533 pm | 218 | ||
ActRII + BG Ki (HEK293 cells) | 0.2 nm | 217 | |||
ActRII + BG Kd - displacing I125 inhibin A | 1100 ± 169 pm | 1270 ± 37 pm | 151 | ||
ActRIIB + BG Kd - displacing I125 inhibin A | 433 ± 27 pm | 704 ± 59 pm | 151 | ||
ActRIIB2 + BG (IC50) - displacing I125 inhibin B | 2.7 nm | 4.0 nm | 218 | ||
TM4 cells ED50 - displacing I125 inhibin A | 75 pm | 6000 pm | 226 | ||
TM4 cells ED50 - displacing I125 inhibin B | 50 pm | 400 pm | 226 | ||
BG (IC50) - displacing I125 inhibin A and inhibin B, respectively | 4.5 nm (34 kDa) | 5.0 nm (34 kDa) | 78 | ||
0.2 nm (31 kDa) | 2.2 nm (31 kDa) | ||||
ActRII + BG (IC50) - displacing 31 kDa I125 inhibin A and inhibin B, respectively | 1.1 nm (34 kDa) | 3.5 nm (34 kDa) | 78 | ||
0.08 nm (31 kDa) | 0.4 nm (31 kDa) | ||||
ActRIIB+ BG (IC50) - displacing 31 kDa I125 inhibin A and inhibin B, respectively | 1.8 nm (34 kDa) | 3.8 nm (34 kDa) | 78 | ||
0.3 nm (31 kDa) | 0.8 nm (31 kDa) |
Abbreviations: ECD, extracellular domain; BG, betaglycan.